The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.
Not required
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
30
Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics
University of Missouri School of Medicine
Columbia, Missouri, United States
RECRUITINGApolipoprotein C turnover rate
Apolipoprotein C turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Triglyceride turnover rate
Triglyceride turnover rate will be assessed by using an intravenous stable isotope labeled glycerol infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein B-100 turnover rate
Apolipoprotein B-100 turnover rate will be assessed by using an intravenous stable isotope labeled amino acid infusion
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein C concentration
Apolipoprotein C concentration
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Triglyceride concentration
Triglyceride concentration
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
Apolipoprotein B-100 concentration
Apolipoprotein B-100 concentration
Time frame: one time, at baseline (this is a cross-sectional, observational study, no intervention)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.